0001104659-14-016477.txt : 20140305 0001104659-14-016477.hdr.sgml : 20140305 20140305170558 ACCESSION NUMBER: 0001104659-14-016477 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20140305 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20140305 DATE AS OF CHANGE: 20140305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 14670142 BUSINESS ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 8-K 1 a14-7458_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 


 

Date of Report:  March 5, 2014

(Date of earliest event reported)

 


 

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

 

Nevada

 

1-7293

 

95-2557091

(State of Incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification Number)

 

1445 Ross Avenue, Suite 1400

Dallas, Texas  75202

(Address of principal executive offices, including zip code)

 

(469) 893-2200

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 8.01                                           Other Events.

 

On March 5, 2014, Tenet Healthcare Corporation (the “Company” or “Tenet”) issued a press release announcing commencement of a private placement offering of $400 million in aggregate principal amount of senior notes. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference. On March 5, 2014, the Company issued a press release announcing the pricing of its offering of senior notes due 2019 and an increase of the offering size to $600 million in aggregate principal amount of senior notes due 2019. A copy of the press release is attached to this report as Exhibit 99.2 and incorporated herein by reference.

 

Item 9.01    Financial Statements and Exhibits.

 

(d)                                 The following exhibits are filed as a part of this Report.

 

Exhibit No.

 

Description

99.1

 

Press release announcing commencement of private placement offering.

99.2

 

Press release announcing pricing of private placement offering.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

TENET HEALTHCARE CORPORATION

 

 

 

 

Date: March 5, 2014

 

 

By:

/s/ Paul Castanon

 

 

Name:    Paul Castanon

 

 

Title:      Vice President, Deputy General Counsel and Corporate Secretary

 

3



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

99.1

 

Press release announcing commencement of private placement offering.

99.2

 

Press release announcing pricing of private placement offering.

 

4


EX-99.1 2 a14-7458_1ex99d1.htm EX-99.1

Exhibit 99.1

 

GRAPHIC

 

Tenet Announces Private Offering of
Senior Notes

 

DALLASMarch 5, 2014 — Tenet Healthcare Corporation (NYSE: THC) is offering to sell $400 million aggregate principal amount of senior notes through a private placement.  The proceeds from the offering will be used for general corporate purposes, including the repayment of indebtedness and drawings under Tenet’s senior secured revolving credit facility and related transaction fees and expenses.

 

The notes being offered have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws.  As a result, they may not be offered or sold in the United States or to any U.S. persons, except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.  Accordingly, the notes are being offered only to “qualified institutional buyers” under Rule 144A of the Securities Act or, outside the United States, to persons other than “U.S. persons” in compliance with Regulation S under the Securities Act.

 

This news release is neither an offer to sell nor a solicitation of an offer to buy, nor shall there be any sale of, these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

 

About Tenet

 

Tenet Healthcare Corporation, a leading health care services company, through its subsidiaries operates 77 hospitals, 187 outpatient centers and Conifer Health Solutions, a leader in business process solutions for health care providers serving more than 700 hospital and other clients nationwide. Tenet’s hospitals and related health care facilities are committed to providing high quality care to patients in the communities they serve. For more information, please visit www.tenethealth.com.

 

# # #

 

Media: Steven Campanini (469) 893-2640

 

Investors: Thomas Rice (469) 893-2522

 

Steven.Campanini@tenethealth.com

 

 

Thomas.Rice@tenethealth.com

 

This release contains “forward-looking statements” — that is, statements that relate to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include, but are not limited to, the factors disclosed under “Forward-Looking Statements” and “Risk Factors” in our Form 10-K for the year ended December 31, 2013, and in our quarterly reports on Form 10-Q, periodic reports on Form 8-K and other filings with the Securities and Exchange Commission. The information contained in this release is as of the date hereof. The Company assumes no obligation to update forward-looking statements contained in this release as a result of new information or future events or developments.

 

Tenet uses its company website to provide important information to investors about the company including the posting of important announcements regarding financial performance and corporate developments.

 


EX-99.2 3 a14-7458_1ex99d2.htm EX-99.2

Exhibit 99.2

 

GRAPHIC

 

Tenet Announces Pricing of Private Offering of
Senior Notes

 

DALLASMarch 5, 2014 — Tenet Healthcare Corporation (NYSE: THC) established today the pricing of the previously announced private offering of senior notes maturing in 2019 (the “notes).  A total of $600 million aggregate principal amount of notes, which will bear interest at a rate of 5.00% per annum, will be issued.

 

The notes will be Tenet’s general unsecured senior obligations and will be subordinated to all of Tenet’s existing and future senior secured obligations to the extent of the value of the collateral securing Tenet’s senior secured obligations, and will be structurally subordinated to all obligations and liabilities of Tenet’s subsidiaries.

 

The proceeds from the offering will be used for general corporate purposes, including the repayment of indebtedness and drawings under Tenet’s senior secured revolving credit facility and related transaction fees and expenses.

 

The notes being offered have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws.  As a result, they may not be offered or sold in the United States or to any U.S. persons, except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the notes are being offered only to “qualified institutional buyers” under Rule 144A of the Securities Act or, outside the United States, to persons other than “U.S. persons” in compliance with Regulation S under the Securities Act.

 

This news release is neither an offer to sell nor a solicitation of an offer to buy, nor shall there be any sale of, these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

 

About Tenet

 

Tenet Healthcare Corporation, a leading health care services company, through its subsidiaries operates 77 hospitals, 187 outpatient centers and Conifer Health Solutions, a leader in business process solutions for health care providers serving more than 700 hospital and other clients nationwide. Tenet’s hospitals and related health care facilities are committed to providing high quality care to patients in the communities they serve. For more information, please visit www.tenethealth.com.

 

# # #

 



 

Media:  Steven Campanini (469) 893-2640

Investors:  Thomas Rice (469) 893-2522

Steven.Campanini@tenethealth.com

Thomas.Rice@tenethealth.com

 

This release contains “forward-looking statements” — that is, statements that relate to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include, but are not limited to, the factors disclosed under “Forward-Looking Statements” and “Risk Factors” in our Form 10-K for the year ended December 31, 2013, and in our quarterly reports on Form 10-Q, periodic reports on Form 8-K and other filings with the Securities and Exchange Commission. The information contained in this release is as of the date hereof. The Company assumes no obligation to update forward-looking statements contained in this release as a result of new information or future events or developments.

 

Tenet uses its company website to provide important information to investors about the company including the posting of important announcements regarding financial performance and corporate developments.

 

2


GRAPHIC 4 g74581mmi001.jpg GRAPHIC begin 644 g74581mmi001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BLO7_$. MF^&M-:^U*?RT'"(.7D;T4=S7B7BGXGZYX@=X;:1M.L3P(H6P[#_:;K^`P*VI MT95-MB)343V/6O&WAW0"4O\`4XEE'_+&,[W_`"'3\:XW4/C?I\99=.TBXG]' MF<1C\ADUP7A3X?ZSXL;SX5%M99^:ZF!PWKM'5C^GO7K&B?"CPQI*JUQ;MJ,X MZR7)RN?91Q^>:U<*-/26K)3G+8XEOC1XBNWV6.D6@/8*KR']"*GB\=_$RY^: M#0BP/3&GR8_4UZ];6=K9QB.UMHH$'\,2!1^E35'M8=(#Y7W/)HO&7Q0B^:7P MOYH]/LCC^35:C^*FOV1_XG/@R[C4=6B5UQ^#+_6O3Z*GVD7O$?*^YQ.F?%GP MKJ#".>YET^4]5NH]HS]1D5V%M=VU[")[6>.>)NCQN&!_$56O]#TG5$*W^FVM MR#WDB4G\^M'KZ]T.X/.;:4M&?JC9!%)^S>V@]4=C17/6%[X MAT^9+76[2.]C9@JW]BIZG_GI&>5^HR/I70UFU8=PHHHI#"BBB@`HHHH`**** M`"BBB@#R/Q5\/_&OBK6'OKNYL!&I*V\/G-B),\#[O7U-1>'_`(,WL>KQ2Z]/ M;/91_,T4#L3(>RG(&!ZU[#16_P!8FE9$>S5[G/>)/%6E>";&T-U;RB&4F.)+ M:,87`Z8R,"N=_P"%U>&O^?74?^_2_P#Q5=/XF\):9XL@@AU/S]MNY=/*?:JI1IRLGN*;DM4=E_PNKPU_ MSZZC_P!^E_\`BJZ;PMXNT_Q=:SW&GQSHD#A&$RA3DC/&":\I^&?@G1_%EG?R MZF)]UO*BIY4FW@@GFNE\6VUG\-?!=Q::"\\(SAI&;.!GL."374^-?A1I= MCH-QJ6B&:*6T0R/$[EUD0=>O(('--TZ,90WK3P$!C'$"O(!X.?>N*^#7B2:#59/#\TA:WN M%:6`$_<<(;G26F\]8\,DF,%E89 M&1ZU<:-*3<4]27.:5SZZG/+8'4_4D@?C M65.BG=R>B+E/:QZC#\:?#3R[)+>_B3^^8@1^0.:[72M7T_6[);S3;J.Y@;C< MAZ'T(Z@^QKA]4^#6@2Z4NK-Z,#V^E>??#OQ!<^&O%\5M(Q M6VNI1;W,9/`.Z%S2B[2/1KCXR>'K:YE@>TU`M$[(Q$:X MR#C^]4?_``NOPY_SYZC_`-^U_P#BJM3_``@\+W%Q+/(;[?*Y=L3\9)R>U>'_ M`&:/^V?LG/E_:?*Z\[=V/Y55.G1GL*4IQ/:K;XR>'KJZAMTM-0#3.J*3&N,D MX_O5Z!7#V_PB\+6US%<1B]WQ.'7-QQD'([5W%/_P!!-1_',/\`9=&/\'F2Y^N%_P#KU)\#?^0;J_\`UWC_`/0375?$+PP_ MBCPQ);6X'VN!A-;Y_B8#E?Q!(^N*UE)1Q%V2E>G8\1\-Z+XHU6&=_#PN3'&P M$ODW'E\D<9Y&:V'\%_$>6-HY(KYT8896O@01Z$;JH^#O%UYX&UB?S;5Y(9/W M=U;-\K`@\$9Z$<]?6O1YOC7X>2VWPV=_+-C_`%915&?KFMZDJBE[JNC.*C;5 MG+^"?`?BG2/&&G7]YIC0V\,A,C^:AP"I'0'WK"^)W_)0=4_WD_\`0%KT;P)\ M2KGQ3XAN=/O+-84=-]MY0+;`.H<^_7/'I7G/Q._Y*#JG^\G_`*`M*FY.K[RZ M#DER:'M/@+_D1='_`.O5:\A^+G_(_P!S_P!<(O\`T&O7_`8QX&T>^'K#7-1U! MX=`$YNA&6;R9O+;9D9YR.,D5[/X2TB+7OA#:Z7,=JW-LZ!O[IWL0?P.#7D=C M=:O\/_%HDD@V75JQ62)_NRH>N#Z$<@_2M:4OBBM[LF2V;-G_`(13XF?W=3_\ M#_\`[.JD'PY\9K>1S-H\FX2!RQF3/7.?O5Z'#\:O#K6H>6TOXYLH'KGM2YZVONH=H=SU(=*^7!_R, MH_Z_?_:E?4E?+2_\C&/^OW_V>L\+]H=7H?4M%%%<9L%%%%`!1110`5B>)/"6 ME>*XK>/5$E9;=BR>7(4Y/7^5;=%--IW0-7,3PWX3TKPI#/%I:RJMPP9_,D+< M@8%;=%%#;;NPM8P=>\%>'_$C>9J.GHT^,>?&2DGYCK^-847P=\)QR!VCO)0/ MX'N#C]`*[NBJ52:5DQ.*91TK1=,T2V^SZ990VL?<1K@M]3U/XU@ZS\-?#FNZ MK-J5]'OH?H011&4D M[W!I6':9IUOI.FV^GVH806Z!(PQR<#WK`UWX=>'_`!%JCZEJ$=PUPZJI*3%1 M@#`XJ*XU/Q;X>R;S34U^S7_EXLAY#_P`!-.L/B9X5OG\J2_-C.#AH M;R,Q,#[YX_6J2FO>C^`M-F;^CZ3:Z'I4&FV0<6\`(0.VX\DGK^-0:WX;T?Q% M`(M5L8[@+]QSPZ?1AR*N6U_9WJAK6[@G4]XI`W\JL5%VG?J.RL<%_P`*;\*> M9N_T[']S[1Q_+-=+HGA30_#JG^R].B@:V*9))'$I>1U11W8X% M-U)RT;!12'UQ0^$WA87?VKRKKS/,\S_CX.,YS_.M35/'GAC2`WVK6+=G'_+. M%O,8_@N:\]\2?&>YN$>W\/VIME/'VF<`O_P%>@_'-:4X57\.A,I1ZG9^/?'E MMX3L3!;LDVJ3+^ZBZB,?WV]O0=Z\Q_X6]XOZ">T/_;L/\:Y_3=%UWQ9J#M9V MUQ?32-F6=R=N?5G/%>O>"OA99Z!)'J&JNE[J"\HH'[J$^P/4^YKH<:5*-I:L MSO*;T-K1K7Q;N,9]Z*Z:BN)R-K!1114C"B MBN2\=>+KOPF^ER6]JMS#<3,+A-I+^6HR2N.X&3SZ548N3LA-V.MHKFX?$_VC MQ;%8Q20-ILND_;UG[_?QG.<8Q1;>/_#EW(Z0WKDK&\JDP.HE5!EBA(^?@=J? M)+L%T=)16+#XMT2>[L;6.\!EU"W-S;@J1NC`)SGMT/!]*I2?$3PS%;P3F]D9 M)XS*H2W=B$!(+D`<+D'DTN278+HZ>BHK:Y@O;6*ZMI5EAF0/&ZG(93R"*X:# MQ)XIU!-4NK:]T&V@L;N:!8[I'#$(>"3NP,^N*<8-@W8[ZLW5?#NC:VFW4]-M M[G_:=!N'T;J*R+'QYIS>&=,U;4R;:74%.RWB1I79@2#M5021QG/N*+WQC%+_ M`&%/HTL-Q;:E?BVE9E.4&"2,<$,".]-0FF*Z,:^^#/A^5S)IUU>Z<_;RY-RC M\^?UK-E^%7B6WR-.\93[>PD:1/Y,:[2/QSX=EU0:/?#EKJ+V,M\P>.40R2"%S'&_3:S@;0?QK13K$\L3@)?AKX^;*GQ,) M%][R;_"H/^%-^);HYO-;M3_O/))_.O2+CQQX>M-5;39KXK,LHA=O*8QHYZ*7 MQM!_&EU+QOX?TK4'L;N]*RQ;?-*1.Z0YZ;V`(7\:I5:O1?@'+$X6S^!D8P;W M7&/JL$`'ZDG^5=/I?PJ\*:8RNUD][(/XKI]X_P"^>!^E=@K*Z!T8,K#((.01 M3JRE6J/=E*$5T(X8(;:)8H(DBC7[J(H4#\!4E%%9%!1110`4444`%<[XBTB[ MU'Q!X?N8(5DM[.XD:X+,!A60J.#UYKHJ*:=G<35SSBQ^'VHV/B'5X(YO^)/< MZ9-:V;EP3!YC!MF.N`=Q^E5]`\$:M%J&E)J&DK&FGL?-N9-2>9'&,?NXL_+G MOGBO3Z*U]M(7(CQU_AIXCBLKR:!@;ZTG6'3#YR_\>WS@CVR'[\\5K:[X2O;< M6EM9:!)>AZFO3**/;R;U%R(S?#UM?6?AZQMM M3D62\BA59F7H6Q7)6?PXLK_3M:76=-A%[=WMQ);W`(+JC'*'(Z<]J[^BH4VK MV*LF>:7_`(3\0WEKX?OYK+S;O3[9K6ZM(+S[.Q'9TD7@=,D5+I_@S5;:WTHB MQCMRFLF\GB6Y,IBC*;*&[$@ MOFU)Q#L#9SY`(^?%&M^&O%^JC4;2:SO9I);HO&\=]'%9^4&!'[H8);'KWYS7 MK-%5[>5[BY$>7ZQX:UZ?6[F33]$>SO);L2)?VUZ!;.@/WI8F)RV,YP.OZIK' M@?6#K&LF'33J,&IRF6.0:DUND9(Y$D8^^![5ZC125:2#D15TRT-AI5I9DJ3; :PI&=N<<`#C/...]6J**Q+"BBB@`HHHH`_]D_ ` end GRAPHIC 5 g74581moi001.jpg GRAPHIC begin 644 g74581moi001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BLO7_$. MF^&M-:^U*?RT'"(.7D;T4=S7B7BGXGZYX@=X;:1M.L3P(H6P[#_:;K^`P*VI MT95-MB)343V/6O&WAW0"4O\`4XEE'_+&,[W_`"'3\:XW4/C?I\99=.TBXG]' MF<1C\ADUP7A3X?ZSXL;SX5%M99^:ZF!PWKM'5C^GO7K&B?"CPQI*JUQ;MJ,X MZR7)RN?91Q^>:U<*-/26K)3G+8XEOC1XBNWV6.D6@/8*KR']"*GB\=_$RY^: M#0BP/3&GR8_4UZ];6=K9QB.UMHH$'\,2!1^E35'M8=(#Y7W/)HO&7Q0B^:7P MOYH]/LCC^35:C^*FOV1_XG/@R[C4=6B5UQ^#+_6O3Z*GVD7O$?*^YQ.F?%GP MKJ#".>YET^4]5NH]HS]1D5V%M=VU[")[6>.>)NCQN&!_$56O]#TG5$*W^FVM MR#WDB4G\^M'KZ]T.X/.;:4M&?JC9!%)^S>V@]4=C17/6%[X MAT^9+76[2.]C9@JW]BIZG_GI&>5^HR/I70UFU8=PHHHI#"BBB@`HHHH`**** M`"BBB@#R/Q5\/_&OBK6'OKNYL!&I*V\/G-B),\#[O7U-1>'_`(,WL>KQ2Z]/ M;/91_,T4#L3(>RG(&!ZU[#16_P!8FE9$>S5[G/>)/%6E>";&T-U;RB&4F.)+ M:,87`Z8R,"N=_P"%U>&O^?74?^_2_P#Q5=/XF\):9XL@@AU/S]MNY=/*?:JI1IRLGN*;DM4=E_PNKPU_ MSZZC_P!^E_\`BJZ;PMXNT_Q=:SW&GQSHD#A&$RA3DC/&":\I^&?@G1_%EG?R MZF)]UO*BIY4FW@@GFNE\6VUG\-?!=Q::"\\(SAI&;.!GL."374^-?A1I= MCH-QJ6B&:*6T0R/$[EUD0=>O(('--TZ,90WK3P$!C'$"O(!X.?>N*^#7B2:#59/#\TA:WN M%:6`$_<<(;G26F\]8\,DF,%E89 M&1ZU<:-*3<4]27.:5SZZG/+8'4_4D@?C M65.BG=R>B+E/:QZC#\:?#3R[)+>_B3^^8@1^0.:[72M7T_6[);S3;J.Y@;C< MAZ'T(Z@^QKA]4^#6@2Z4NK-Z,#V^E>??#OQ!<^&O%\5M(Q M6VNI1;W,9/`.Z%S2B[2/1KCXR>'K:YE@>TU`M$[(Q$:X MR#C^]4?_``NOPY_SYZC_`-^U_P#BJM3_``@\+W%Q+/(;[?*Y=L3\9)R>U>'_ M`&:/^V?LG/E_:?*Z\[=V/Y55.G1GL*4IQ/:K;XR>'KJZAMTM-0#3.J*3&N,D MX_O5Z!7#V_PB\+6US%<1B]WQ.'7-QQD'([5W%/_P!!-1_',/\`9=&/\'F2Y^N%_P#KU)\#?^0;J_\`UWC_`/0375?$+PP_ MBCPQ);6X'VN!A-;Y_B8#E?Q!(^N*UE)1Q%V2E>G8\1\-Z+XHU6&=_#PN3'&P M$ODW'E\D<9Y&:V'\%_$>6-HY(KYT8896O@01Z$;JH^#O%UYX&UB?S;5Y(9/W M=U;-\K`@\$9Z$<]?6O1YOC7X>2VWPV=_+-C_`%915&?KFMZDJBE[JNC.*C;5 MG+^"?`?BG2/&&G7]YIC0V\,A,C^:AP"I'0'WK"^)W_)0=4_WD_\`0%KT;P)\ M2KGQ3XAN=/O+-84=-]MY0+;`.H<^_7/'I7G/Q._Y*#JG^\G_`*`M*FY.K[RZ M#DER:'M/@+_D1='_`.O5:\A^+G_(_P!S_P!<(O\`T&O7_`8QX&T>^'K#7-1U! MX=`$YNA&6;R9O+;9D9YR.,D5[/X2TB+7OA#:Z7,=JW-LZ!O[IWL0?P.#7D=C M=:O\/_%HDD@V75JQ62)_NRH>N#Z$<@_2M:4OBBM[LF2V;-G_`(13XF?W=3_\ M#_\`[.JD'PY\9K>1S-H\FX2!RQF3/7.?O5Z'#\:O#K6H>6TOXYLH'KGM2YZVONH=H=SU(=*^7!_R, MH_Z_?_:E?4E?+2_\C&/^OW_V>L\+]H=7H?4M%%%<9L%%%%`!1110`5B>)/"6 ME>*XK>/5$E9;=BR>7(4Y/7^5;=%--IW0-7,3PWX3TKPI#/%I:RJMPP9_,D+< M@8%;=%%#;;NPM8P=>\%>'_$C>9J.GHT^,>?&2DGYCK^-847P=\)QR!VCO)0/ MX'N#C]`*[NBJ52:5DQ.*91TK1=,T2V^SZ990VL?<1K@M]3U/XU@ZS\-?#FNZ MK-J5]'OH?H011&4D M[W!I6':9IUOI.FV^GVH806Z!(PQR<#WK`UWX=>'_`!%JCZEJ$=PUPZJI*3%1 M@#`XJ*XU/Q;X>R;S34U^S7_EXLAY#_P`!-.L/B9X5OG\J2_-C.#AH M;R,Q,#[YX_6J2FO>C^`M-F;^CZ3:Z'I4&FV0<6\`(0.VX\DGK^-0:WX;T?Q% M`(M5L8[@+]QSPZ?1AR*N6U_9WJAK6[@G4]XI`W\JL5%VG?J.RL<%_P`*;\*> M9N_T[']S[1Q_+-=+HGA30_#JG^R].B@:V*9))'$I>1U11W8X% M-U)RT;!12'UQ0^$WA87?VKRKKS/,\S_CX.,YS_.M35/'GAC2`WVK6+=G'_+. M%O,8_@N:\]\2?&>YN$>W\/VIME/'VF<`O_P%>@_'-:4X57\.A,I1ZG9^/?'E MMX3L3!;LDVJ3+^ZBZB,?WV]O0=Z\Q_X6]XOZ">T/_;L/\:Y_3=%UWQ9J#M9V MUQ?32-F6=R=N?5G/%>O>"OA99Z!)'J&JNE[J"\HH'[J$^P/4^YKH<:5*-I:L MSO*;T-K1K7Q;N,9]Z*Z:BN)R-K!1114C"B MBN2\=>+KOPF^ER6]JMS#<3,+A-I+^6HR2N.X&3SZ548N3LA-V.MHKFX?$_VC MQ;%8Q20-ILND_;UG[_?QG.<8Q1;>/_#EW(Z0WKDK&\JDP.HE5!EBA(^?@=J? M)+L%T=)16+#XMT2>[L;6.\!EU"W-S;@J1NC`)SGMT/!]*I2?$3PS%;P3F]D9 M)XS*H2W=B$!(+D`<+D'DTN278+HZ>BHK:Y@O;6*ZMI5EAF0/&ZG(93R"*X:# MQ)XIU!-4NK:]T&V@L;N:!8[I'#$(>"3NP,^N*<8-@W8[ZLW5?#NC:VFW4]-M M[G_:=!N'T;J*R+'QYIS>&=,U;4R;:74%.RWB1I79@2#M5021QG/N*+WQC%+_ M`&%/HTL-Q;:E?BVE9E.4&"2,<$,".]-0FF*Z,:^^#/A^5S)IUU>Z<_;RY-RC M\^?UK-E^%7B6WR-.\93[>PD:1/Y,:[2/QSX=EU0:/?#EKJ+V,M\P>.40R2"%S'&_3:S@;0?QK13K$\L3@)?AKX^;*GQ,) M%][R;_"H/^%-^);HYO-;M3_O/))_.O2+CQQX>M-5;39KXK,LHA=O*8QHYZ*7 MQM!_&EU+QOX?TK4'L;N]*RQ;?-*1.Z0YZ;V`(7\:I5:O1?@'+$X6S^!D8P;W M7&/JL$`'ZDG^5=/I?PJ\*:8RNUD][(/XKI]X_P"^>!^E=@K*Z!T8,K#((.01 M3JRE6J/=E*$5T(X8(;:)8H(DBC7[J(H4#\!4E%%9%!1110`4444`%<[XBTB[ MU'Q!X?N8(5DM[.XD:X+,!A60J.#UYKHJ*:=G<35SSBQ^'VHV/B'5X(YO^)/< MZ9-:V;EP3!YC!MF.N`=Q^E5]`\$:M%J&E)J&DK&FGL?-N9-2>9'&,?NXL_+G MOGBO3Z*U]M(7(CQU_AIXCBLKR:!@;ZTG6'3#YR_\>WS@CVR'[\\5K:[X2O;< M6EM9:!)>AZFO3**/;R;U%R(S?#UM?6?AZQMM M3D62\BA59F7H6Q7)6?PXLK_3M:76=-A%[=WMQ);W`(+JC'*'(Z<]J[^BH4VK MV*LF>:7_`(3\0WEKX?OYK+S;O3[9K6ZM(+S[.Q'9TD7@=,D5+I_@S5;:WTHB MQCMRFLF\GB6Y,IBC*;*&[$@ MOFU)Q#L#9SY`(^?%&M^&O%^JC4;2:SO9I);HO&\=]'%9^4&!'[H8);'KWYS7 MK-%5[>5[BY$>7ZQX:UZ?6[F33]$>SO);L2)?VUZ!;.@/WI8F)RV,YP.OZIK' M@?6#K&LF'33J,&IRF6.0:DUND9(Y$D8^^![5ZC125:2#D15TRT-AI5I9DJ3; :PI&=N<<`#C/...]6J**Q+"BBB@`HHHH`_]D_ ` end